Tango Therapeutics, акция обыкновенная (US87583X1090, TNGX, TNGX.P)

Tango Therapeutics Inc (formerly BCTG Acquisition Corp) is an operator of a biotechnology company intended to develop novel drugs for the treatment of cancer. The company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.

• Выручка
• Чистая прибыль
• EBITDA
• Активы
• Капитал
• Рентабельность по EBITDA (%)
• Чистый долг / EBITDA
• Общий долг / Капитал